This is a Provider Selection Regime (PSR) confirmation of contract award notice. The contract has been awarded following Direct Award Process A under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award.

The contract relates to the provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages in the Midlands Region.

The contract will run from 1 October 2026 to 30 September 2030.

Estimated lifetime contract value (1 October 2026 to 30 September 2030):£4,813,860

This is a Provider Selection Regime (PSR) confirmation of contract award notice. The contract has been awarded following Direct Award Process A under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award.

The contract relates to the provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages in the Midlands Region.

The provider is commissioned to deliver care in line with the Hyperbaric Oxygen Therapy service specification published in 2018 (https://www.england.nhs.uk/wp-content/uploads/2018/11/1766-HBOT-Service-Specification.pdf.)

The contract includes service development requirements and associated improvement plans to support the provider's progression towards compliance with the service specification published in 2025 (https://www.england.nhs.uk/wp-content/uploads/2018/11/Hyperbaric-oxygen-therapy-services-all-ages-Service-specification-January-2025.pdf)

The contract will run from 1 October 2026 to 30 September 2030.

Estimated lifetime contract value (1 October 2026 to 30 September 2030):£4,813,860

The award decision-maker was the National Commissioning Group (NCG).

No conflicts or potential conflicts of interest were declared by the decision-makers in reaching the decision to award.